The Scientific Advisory Board of HTA

The Scientific Advisory Board of HTA supports the DAHTA from a methodological and technical perspective in the following matters in particular:

• Scientific queries from all branches of medicine, biometrics, epidemiology and health system research (Public Health)
• Methodological procedure for the preparation of HTA reports and their further development
• Development of scientific standards in association with the HTA information system
• Promotion of scientific flow of information within the German health care system
• Collaboration and information exchange with other scientific structures, both domestic and in other countries
• Evaluation of research assignments in the field of HTA (Review)

Members

• Chair: Dr. Monika Lelgemann, M.Sc. (Medical Service of the National Association of Statutory Health Insurance Funds, Essen)
• Dr. Gerd Antes (German Cochrane Centre, Freiburg)
• Prof. Dr. Sabine Bartholomeyczik (University of Witten/Herdecke, Institute for Nursing Science)
• Prof. Dr. Heike Bickeböller (University of Göttingen, Department of Genetic Epidemiology)
• Prof. Dr. Robert Francke (University of Bremen, Institute for Health and Medical Law)
• Dr. Bernhard Gibis (National Association of Statutory Health Insurance Physicians, Berlin)
• Dr. Tanja Krones (Clinical Ethics/Clinical Ethics Committee, University Hospital of Zürich)
• Prof. Dr. Walter Lehmacher (University of Cologne, Institute for Medical Statistics, Informatics and Epidemiology)
• Prof. Dr. Christian Ohmann (University of Düsseldorf, Coordination Centre for Clinical Studies)
• Dr. Matthias Perleth, MPH (Joint Federal Committee, Department of Medical Specialist Consultancy, Berlin)
• Prof. Dr. Anita B. Pfaff (University of Augsburg, Institute for Economics)
• Dr. Constanze Schäfer (North Rhine Chamber of Pharmacists, Düsseldorf)
• Prof. Dr. Dr. Wilfried Wagner (University of Mainz, Cinic for Oral and Maxillofacial surgery)
• Dr. Claudia Wild (Ludwig Boltzmann Institute for HTA, Vienna)